ArrowMark Colorado Holdings LLC CGON CG ONCOLOGY INC

Ownership history in ArrowMark Colorado Holdings LLC  ·  10 quarters on record

AI Ownership Summary

ArrowMark Colorado Holdings LLC reported CG ONCOLOGY INC (CGON) in 10 quarterly 13F filings from 2024 Q1 through 2026 Q2. Peak portfolio weight reached 0.46% in 2026 Q2. The latest visible filing shows CGON at 0.46% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CGON ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ArrowMark Colorado Holdings LLC's position in CG ONCOLOGY INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

CGON was reported at 0.46% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.46% in 2026 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How ArrowMark Colorado Holdings LLC held CGON — position size vs. price
% of Fund (quarterly)    CGON price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 155,354 -30,958 -16.6% 0.46% $11.0M 2026-08-13 $74.71
2026 Q1 REDUCED 24.2% +8.9% 186,312 -59,520 -24.2% 0.34% $12.6M 2026-05-15 $66.93
2025 Q4 REDUCED 245,832 -11,398 -4.4% 0.22% $10.2M 2026-02-17 $53.87
2025 Q3 REDUCED 12.2% -1.0% 257,230 -35,776 -12.2% 0.19% $10.4M 2025-11-14 $41.01
2025 Q2 ADDED 293,006 +57,812 +24.6% 0.14% $7.6M 2025-08-14 $25.96
2025 Q1 ADDED 235,194 +10,612 +4.7% 0.09% $5.8M 2025-05-15 $25.35
2024 Q4 REDUCED 224,582 -5,808 -2.5% 0.09% $6.4M 2025-02-14 $28.52
2024 Q3 ADDED 230,390 +34,131 +17.4% 0.11% $8.7M 2024-11-14 $35.50
2024 Q2 ADDED 196,259 +152 +0.1% 0.07% $6.2M 2024-08-14 $33.23
2024 Q1 INITIATED 196,107 0.10% $8.6M 2024-05-15 $28.01

FAQ About ArrowMark Colorado Holdings LLC and CGON

These are the practical questions this page is built to answer before you even open the full history table.

How long has ArrowMark Colorado Holdings LLC reported owning CGON?

ArrowMark Colorado Holdings LLC reported CGON across 10 quarterly 13F filings, from 2024 Q1 through 2026 Q2.

What was the largest reported CGON position in ArrowMark Colorado Holdings LLC's portfolio?

The largest reported portfolio weight for CGON was 0.46% in 2026 Q2.

What is the latest reported CGON position on this page?

The most recent filing on this page is 2026 Q2, when ArrowMark Colorado Holdings LLC reported 155,354 shares, equal to 0.46% of portfolio, with an estimated market value of $11.0M.

What does the chart on this CGON ownership page compare?

The chart compares ArrowMark Colorado Holdings LLC's quarterly CGON portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did ArrowMark Colorado Holdings LLC time their CGON position?

Based on 13F filing dates vs. subsequent CGON price moves, ArrowMark Colorado Holdings LLC correctly timed 5 out of 9 reported position changes (56%). The annualised alpha on CGON relative to SPY over the holding period was +496.9%.

← Back to ArrowMark Colorado Holdings LLC Holdings